STEVEY SANDERS: Open Payments
NPI 1962121095 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,037 in 115 payments from 20 companies in 2025. Trend: 2023 $1,195 · 2024 $1,872 · 2025 $2,037
Food & beverage: $2,037
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $360 |
| Novo Nordisk Inc | 16 | $264 |
| AstraZeneca Pharmaceuticals LP | 10 | $228 |
| PFIZER INC. | 10 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $152 |
| Amgen Inc. | 9 | $137 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
Products named: VRAYLAR, CAPLYTA, NURTEC ODT, Ozempic, EVENITY, ELIQUIS, JARDIANCE, UBRELVY.
Industry payments across FL — which companies pay providers there.
